NADIA RUDMAN: Open Payments
NPI 1699409003 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 16 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $432
Food & beverage: $347Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| GENZYME CORPORATION | 2 | $66 |
| Organon LLC | 2 | $35 |
| Galderma Laboratories, L.P. | 2 | $31 |
| Incyte Corporation | 1 | $30 |
| PFIZER INC. | 1 | $22 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $22 |
| Amgen Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: DUPIXENT, SKYRIZI, VTAMA, AKLIEF, OPZELURA, RINVOQ, CIBINQO, Cabtreo.
Industry payments across RI — which companies pay providers there.
